Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 5, 2022
Patent Application Number
16486688
Date Filed
February 20, 2018
Patent Citations Received
Patent Primary Examiner
The present invention provides methods for treating, reducing the severity, or inhibiting the growth of cancer (e.g., lung cancer). The methods of the present invention comprise administering a therapeutically effective amount of a programmed death 1 (PD-1) antagonist (e.g., an anti-PD-1 antibody), to a subject with lung cancer wherein the cancer tissue expresses PD-L1.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
